jj jj jj jj jj jj
practical approach 5th edition by Virginia P. Arcangelo and
jj jj jj jj jj jj jj jj jj
Peterson Chapters 1-56
jj jj jj
, TABLE j j OF j j CONTENT
Chapter 1: Issues j j for j j the j j Practitioner j j in j j Drug j j Therapy
Chapter 2: Pharmacokinetic j j j j Basis j j j j of jj jj Therapeutics j j j j and jj jj Pharmacodynamic j j
Principles
j j
Chapter 3: Impact of Drug j j j j j j Interactions j j and j j Adverse j j Events j j on
Therapeutics
j j
Chapter 4: Principles of jj jj j j Pharmacotherapy j j j j in j j Pediatrics, jj jj Pregnancy jj jj and
Lactation
j j
Chapter 5: Pharmacotherapy jj jj Principles jj jj in jj jj Older jj jj Adults
Chapter j j 6: j j Principles j j of j j Antimicrobial j j Therapy
Chapter j j 7: j j Pharmacogenomics
Chapter j j 8: j j The j j Economics j j of j j Pharmacotherapeutics
Chapter j j 9: j j Principles j j of j j Pharmacology j j in j j Pain j j Management
Chapter j j 10: j j Pain j j Management j j in j j Opioid j j Use j j Disorder j j (OUD) j j Patients
Chapter j j 11: j j Cannabis j j and j j Pain j j Management
Chapter j j 12: j j Dermatitis
Chapter j j 13: j j Bacterial, j j Fungal, j j and j j Viral j j Infections j j of j j the j j Skin
Chapter j j 14: j j Psoriasis
Chapter j j 15: j j Acne j j Vulgaris j j and j j Rosacea
Chapter j j 16: j j Ophthalmic j j Disorders
Chapter j j 17: j j Otitis j j Media j j and j j Otitis j j Externa
Chapter j j 18: j j Hypertension
Chapter j j 19: j j Hyperlipidemia
Chapter j j 20: j j Chronic j j Stable j j Angina j j and j j Myocardial j j Infarction
Chapter j j 21: j j Heart j j Failure
Chapter j j 22: j j Arrhythmias
Chapter j j 23: j j Respiratory j j Infections
Chapter j j 24: j j Asthma j j and j j Chronic j j Obstructive j j Pulmonary j j Disease
Chapter j j 25: Gastric, jj jj Functional jj jj and jj jj Inflammatory jj jj Bowel jj jj Disorders
Chapter j j 26: j j Gastroesophageal j j Reflux j j Disease j j and j j Peptic j j Ulcer j j Disease
Chapter j j 27: j j Liver j j Diseases
, Chapter 28: Urinary j j Tract j j Infection
Chapter 29: Prostatic j j Disorders jj jj and j j Erectile jj jj Dysfunction
Chapter 30: Overactive j j j j Bladder
Chapter 31: Sexually j j j j Transmitted j j j j Infections
Chapter 32: Osteoarthritis j j j j and jj jj Gout
Chapter 33: Osteoporosis
Chapter 34: Rheumatoid j j j j Arthritis
Chapter 35: Headaches
Chapter 36: Seizure jj jj Disorders
Chapter 37: Alzheimer’s j j j j Disease
Chapter 38: Parkinson j j j j Disease
Chapter 39: Major Depressive
j j j j Disorder j j and j j Bipolar
Disorders
j j
Chapter 40: Anxiety j j Disorders
Chapter 41: Sleep j j Disorders
Chapter 42: Attention j j j j Deficit j j j j Hyperactivity j j j j Disorder
Chapter 43: Substance j j Use j j Disorders
Chapter 44: Diabetes jj jj Mellitus
Chapter 45: Thyroid j j and j j Parathyroid j j Disorders
Chapter 46: Allergies j j and j j Allergic j j Reactions
Chapter 47: Human j j j j Immunodeficiency j j j j Virus
Chapter 48: Organ j j Transplantation
Chapter 49: Pharmacotherapy j j j j for j j j j Select j j j j Thromboembolic j j
Disorders
j j
Chapter 50: Anemias
Chapter 51: Immunizations
Chapter 52: Smoking j j Cessation
Chapter 53: Weight j j Loss
Chapter 54: Contraception
Chapter 55: Menopause
Chapter 56: Vaginitis
, Chapter 1 Issues for the Practitioner in Drug Therapy
jj jj jj jj jj jj jj jj
MULTIPLE CHOICE jj
1. Nurse practitioner prescriptive authority is regulated by:
jj jj jj jj jj jj
A. The National Council of State Boards of Nursing
jj jj jj jj jj jj jj
B. The U.S. Drug Enforcement Administration
jj jj jj jj
C. The State Board of Nursing for each state
jj jj jj jj jj jj jj
D. The State Board of Pharmacy
jj jj jj jj
Answer: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
jj jj jj jj jj jj jj
A. The National Council of State Boards of Nursing
jj jj jj jj jj jj jj
B. The U.S. Drug Enforcement Administration
jj jj jj jj
C. The State Board of Nursingjj jj jj jj
D. The State Board of Medical Examiners
jj jj jj jj jj
Answer: D PTS: 1
3. Clinical judgment in prescribing includes:
jj jj jj jj
A. Factoring in the cost to the patient of the medication prescribed
jj jj jj jj jj jj jj jj jj jj
B. Always prescribing the newest medication available for the disease process
jj jj jj jj jj jj jj jj jj
C. Handing out drug samples to poor patients jj jj jj jj jj jj
D. Prescribing all generic medications to cut costs jj jj jj jj jj jj
Answer: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
jj jj jj jj jj jj jj jj jj
A. Asking the patient what drug they think would work best for them
jj jj jj jj jj jj jj jj jj jj jj
B. Consulting nationally recognized guidelines for disease management
jj jj jj jj jj jj
C. Prescribing medications that are available as samples before writing a prescription
jj jj jj jj jj jj jj jj jj jj
D. Following U.S. Drug Enforcement Administration (DEA) guidelines
jj jj jj jj jj jj
for prescribing
jj jj
Answer: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
jj jj jj jj jj jj jj jj jj
A. The demonstrated ability of nurse practitioners to control costs and improve
jj jj jj jj jj jj jj jj jj jj
jj patient outcomes jj
B. The fact that nurse practitioners will be able to practice independently
jj jj jj jj jj jj jj jj jj jj
C. The fact that nurse practitioners will have full reimbursement under health-
jj jj jj jj jj jj jj jj jj jj
care reform
jj jj
D. The ability to shift accountability for Medicaid to the state level
jj jj jj jj jj jj jj jj jj jj
Answer: A PTS: 1